The Cardiac Assist Devices Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031.
Cardiac assist devices are used to treat end-stage heart failure and are tailored to the individual's needs. These are designed to assist the heart in operating normally by taking over its function when it becomes weak. Factors driving the growth of the cardiac assist devices market include an increase in the elderly population, which has led to the rise in cardiovascular disorders and an increase in demand for ventricular assist devices due to a scarcity of organ donors. Furthermore, during the forecast period, growth in the number of product approvals is expected to give lucrative prospects for worldwide market advancement. Also, increasing R&D activities, government initiatives to use sustainable components for production, and investments by prominent players are factors expected to create lucrative growth opportunities in terms of revenue for players operating in the global Assist Devices market over the forecast period.
However, high cost and some risks associated with ventricular assist device implantation procedures, such as infection, blood clotting, device problems such as power failure or pumping troubles, coupled with the COVID-19 outbreak, are factors that may limit the growth of the target market during the forecast period.
The Assist Devices market is segmented based on product type, modality, and end-users. Based on the product, the market is segmented as Ventricular Assist Device (VAD) (LVAD, RIVAD, BIVAD) and Intra-Aortic Balloon Pump. Based on modality, the market is segmented into implantable and transcutaneous. The market is segmented into hospitals and ambulatory surgical centres based on end-users.
Based On Product, The Implantable Segment Is Accounted As A Significant Contributor In The Assist Devices Market.
The implantable category is expected to hold a significant share in the global Assist Devices market in 2021. This growth is due to patients who are unfit for heart transplants increasingly preferring long-term therapeutic options, and this segment is expected to grow at a lucrative rate in the coming years. The market is seeing the introduction of new players with cutting-edge technologies. Furthermore, the increased number of patients with end-stage heart failure who require left ventricular assist devices has supported the segment's rise.
VAD Segment Witnessed Growth At A Rapid Rate
The Ventricular Assist Devices segment is projected to grow at a rapid rate in the global Assist Devices market. The market is expected to grow due to an increase in the burden of cardiovascular illnesses and the rate of heart failure. Furthermore, an increase in the geriatric population has led to a rise in cardiovascular disorders and an increase in demand for ventricular assist devices due to a scarcity of organ donors, especially in countries such as the US, Germany, UK, China and India.
In The Region, The North America Assist Devices Market Holds A Significant Revenue Share.
The North America Assist Devices market is expected to register the highest market share in terms of revenue soon. The growing demand for innovative technology in Cardiac Assist Devices, as well as the rising prevalence of chronic disease in the region, are driving regional growth. In addition, the development of technologically advanced healthcare facilities in the United States is expected to increase treatment numbers and enhance the market growth.
The Global Cardiac Assist Devices market has the most potential for future growth in Europe and Asia-Pacific. This is related to an increase in the burden of chronic diseases in both European and Asian countries. The cardiac assist devices market in countries such as China, India, and Brazil is projected to expand at a significant growth rate during the forecast period due to increased awareness among people about heart diseases and their treatment.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 8.0 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Modality, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Terumo Corporation, Medtronic PLC, Maquette GmbH, Abbott Laboratories, A biomed, Inc., Belton Sp. z ox, Nocardia Systems, LLC, St. Jude Medical Inc, CARMAT, Crave SA, Terumo Heart, Inc., Nova Pump GmbH, Getinge AB, Belton Ltd., Meryl Life Sciences Pvt. Ltd., Throated Corporation, Cardiac Assist, Inc., Berlin Heart GmbH Reliant Heart, In., Senko Medical Instrument Mfg. CO., LTD (Japan), Teleflex Incorporated, Windmill Cardiovascular Systems, Inc. (WCS), Zeon Corporation, and others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Cardiac Assist Devices Market by Modality
Cardiac Assist Devices Market by Products
Cardiac Assist Devices Market by End-Users
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.